Thermo Fisher Scientific (NYSE:TMO) just announced a big win for shareholders a $5 billion stock buyback plan with no expiration date. That means the company can repurchase shares at its own pace, ...

The molecular cloning workflow requires QC checkpoints both before and after restriction endonuclease digestion to minimize ...

Scientific announced that its Board of Directors has authorized the repurchase of $5B of shares of its common stock in the ...

Diamond Hill Capital, an investment management company, released its “Large Cap Fund” third-quarter 2025 investor letter. A ...

Thermo Fisher Scientific Inc. (NYSE:TMO) is one of the best stocks to invest in, according to billionaire D.E. Shaw.

Preview this article 1 min October saw not just one, but four different M&A deals with valuations over $1 billion. Power50: ...

A Julia Landon College Prep eighth-grader won $10,000 and one of the top five prizes in Thermo Fisher Scientific's Junior ...

In today’s Pharmaceutical Executive Daily, we cover Thermo Fisher’s $8 billion agreement to acquire Clario Holdings, Eli ...

Thermo Fisher Scientific has agreed to acquire Clario Holdings for nearly $8.9 billion, in a deal that would give it control of a widely used digital toolkit for managing clinical trial data.

Thermo Fisher Scientific agreed to acquire endpoint data solutions provider Clario Holdings from a shareholder group for ...

Thermo Fisher Scientific Inc., a leading U.S.-based medical equipment manufacturer, is reportedly close to finalizing an ...

Thermo Fisher's Dr. Annika Volp shares insights on using extrusion for mechanical recycling of marine plastics, integrating ...